DOCSLIB.ORG

1Gw9 Lichtarge Lab 2006

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1Gw9 Lichtarge Lab 2006 Pages 1–20 1gw9 Evolutionary trace report by report maker January 27, 2010 4.3.1 Alistat 19 4.3.2 CE 19 4.3.3 DSSP 19 4.3.4 HSSP 19 4.3.5 LaTex 19 4.3.6 Muscle 19 4.3.7 Pymol 19 4.4 Note about ET Viewer 19 4.5 Citing this work 19 4.6 About report maker 19 4.7 Attachments 19 1 INTRODUCTION From the original Protein Data Bank entry (PDB id 1gw9): Title: Tri-iodide derivative of xylose isomerase from streptomyces rubiginosus Compound: Mol id: 1; molecule: xylose isomerase; chain: a; ec: 5.3.1.5 Organism, scientific name: Streptomyces Rubiginosus 1gw9 contains a single unique chain 1gw9A (385 residues long). CONTENTS 2 CHAIN 1GW9A 1 Introduction 1 2.1 P24300 overview 2 Chain 1gw9A 1 From SwissProt, id P24300, 96% identical to 1gw9A: 2.1 P24300 overview 1 Description: Xylose isomerase (EC 5.3.1.5). 2.2 Multiple sequence alignment for 1gw9A 1 Organism, scientific name: Streptomyces rubiginosus. 2.3 Residue ranking in 1gw9A 1 Taxonomy: Bacteria; Actinobacteria; Actinobacteridae; Actinomy- 2.4 Top ranking residues in 1gw9A and their position on cetales; Streptomycineae; Streptomycetaceae; Streptomyces. the structure 2 Function: Involved in D-xylose catabolism. 2.4.1 Clustering of residues at 25% coverage. 2 Catalytic activity: D-xylose = D-xylulose. 2.4.2 Overlap with known functional surfaces at Cofactor: Binds 2 magnesium ions per subunit (By similarity). 25% coverage. 2 Subunit: Homotetramer. 2.4.3 Possible novel functional surfaces at 25% Subcellular location: Cytoplasmic. coverage. 16 Similarity: Belongs to the xylose isomerase family. Caution: According to the crystallographic study residue 40 could 3 Notes on using trace results 18 be Gln. 3.1 Coverage 18 About: This Swiss-Prot entry is copyright. It is produced through a 3.2 Known substitutions 18 collaboration between the Swiss Institute of Bioinformatics and the 3.3 Surface 18 EMBL outstation - the European Bioinformatics Institute. There are 3.4 Number of contacts 18 no restrictions on its use as long as its content is in no way modified 3.5 Annotation 18 and this statement is not removed. 3.6 Mutation suggestions 18 2.2 Multiple sequence alignment for 1gw9A 4 Appendix 18 For the chain 1gw9A, the alignment 1gw9A.msf (attached) with 27 4.1 File formats 18 sequences was used. The alignment was assembled through combi- 4.2 Color schemes used 18 nation of BLAST searching on the UniProt database and alignment 4.3 Credits 19 using Muscle program. It can be found in the attachment to this 1 Lichtarge lab 2006 2.4 Top ranking residues in 1gw9A and their position on the structure In the following we consider residues ranking among top 25% of residues in the protein . Figure 3 shows residues in 1gw9A colored by their importance: bright red and yellow indicate more conser- ved/important residues (see Appendix for the coloring scheme). A Pymol script for producing this figure can be found in the attachment. Fig. 1. Residues 2-193 in 1gw9A colored by their relative importance. (See Appendix, Fig.29, for the coloring scheme.) Fig. 2. Residues 194-386 in 1gw9A colored by their relative importance. (See Appendix, Fig.29, for the coloring scheme.) report, under the name of 1gw9A.msf. Its statistics, from the alistat program are the following: Fig. 3. Residues in 1gw9A, colored by their relative importance. Clockwise: front, back, top and bottom views. Format: MSF Number of sequences: 27 Total number of residues: 10273 2.4.1 Clustering of residues at 25% coverage. Fig. 4 shows the Smallest: 371 top 25% of all residues, this time colored according to clusters they Largest: 385 belong to. The clusters in Fig.4 are composed of the residues listed Average length: 380.5 in Table 1. Alignment length: 385 Table 1. Average identity: 44% cluster size member Most related pair: 99% color residues Most unrelated pair: 21% red 79 3,5,10,11,14,16,17,18,46,47 Most distant seq: 67% 52,53,54,55,57,87,88,90,94 102,105,111,134,135,137,138 Furthermore, 9% of residues show as conserved in this alignment. 139,140,141,142,179,181,182 The alignment consists of 11% eukaryotic ( 11% plantae), and 183,184,186,187,190,191,193 85% prokaryotic sequences. (Descriptions of some sequences were 195,197,202,213,215,217,220 not readily available.) The file containing the sequence descriptions 221,223,224,226,235,241,243 can be found in the attachment, under the name 1gw9A.descr. 245,246,247,249,253,254,255 257,260,261,282,283,285,286 287,289,298,300,303,306,307 2.3 Residue ranking in 1gw9A 308,311,313,317 blue 7 22,24,25,26,27,30,292 The 1gw9A sequence is shown in Figs. 1–2, with each residue colo- red according to its estimated importance. The full listing of residues continued in next column in 1gw9A can be found in the file called 1gw9A.ranks sorted in the attachment. 2 Fig. 4. Residues in 1gw9A, colored according to the cluster they belong to: red, followed by blue and yellow are the largest clusters (see Appendix for the coloring scheme). Clockwise: front, back, top and bottom views. The corresponding Pymol script is attached. Table 1. continued cluster size member color residues yellow 5 124,168,172,173,174 Table 1. Clusters of top ranking residues in 1gw9A. 2.4.2 Overlap with known functional surfaces at 25% coverage. The name of the ligand is composed of the source PDB identifier and the heteroatom name used in that file. Iodide ion binding site. Table 2 lists the top 25% of residues at the interface with 1gw9AIOD1400 (iodide ion). The following table (Table 3) suggests possible disruptive replacements for these residues (see Section 3.6). Table 2. res type subst’s cvg noc/ dist antn (%) bb (A˚ ) 137 W W(100) 0.09 1/1 4.83 site 141 E E(100) 0.09 3/0 4.13 138 G G(92) 0.18 2/2 3.71 P(7) Table 2. The top 25% of residues in 1gw9A at the interface with iodide ion.(Field names: res: residue number in the PDB entry; type: amino acid type; substs: substitutions seen in the alignment; with the percentage of each type in the bracket; noc/bb: number of contacts with the ligand, with the num- ber of contacts realized through backbone atoms given in the bracket; dist: distance of closest apporach to the ligand. ) 3 Table 3. type in the bracket; noc/bb: number of contacts with the ligand, with the num- res type disruptive ber of contacts realized through backbone atoms given in the bracket; dist: mutations distance of closest apporach to the ligand. ) 137 W (KE)(TQD)(SNCRG)(M) 141 E (FWH)(YVCARG)(T)(SNKLPI) 138 G (R)(KE)(H)(FYQWD) Table 5. res type disruptive Table 3. List of disruptive mutations for the top 25% of residues in mutations 1gw9A, that are at the interface with iodide ion. 16 W (KE)(TQD)(SNCRG)(M) 54 H (E)(TQMD)(SNKVCLAPIG)(YR) 94 F (E)(K)(TQD)(SNCG) Table 5. List of disruptive mutations for the top 25% of residues in 1gw9A, that are at the interface with iodide ion. Fig. 5. Residues in 1gw9A, at the interface with iodide ion, colored by their relative importance. The ligand (iodide ion) is colored green. Atoms further than 30A˚ away from the geometric center of the ligand, as well as on the line of sight to the ligand were removed. (See Appendix for the coloring scheme for the protein chain 1gw9A.) Fig. 6. Residues in 1gw9A, at the interface with iodide ion, colored by their relative importance. The ligand (iodide ion) is colored green. Atoms further than 30A˚ away from the geometric center of the ligand, as well as on the line Figure 5 shows residues in 1gw9A colored by their importance, at the of sight to the ligand were removed. (See Appendix for the coloring scheme interface with 1gw9AIOD1400. for the protein chain 1gw9A.) Iodide ion binding site. Table 4 lists the top 25% of residues at the interface with 1gw9AIOD1410 (iodide ion). The following table (Table 5) suggests possible disruptive replacements for these residues Figure 6 shows residues in 1gw9A colored by their importance, at the (see Section 3.6). interface with 1gw9AIOD1410. Iodide ion binding site. Table 6 lists the top 25% of residues at Table 4. the interface with 1gw9AIOD1405 (iodide ion). The following table res type subst’s cvg noc/ dist antn (Table 7) suggests possible disruptive replacements for these residues (%) bb (A˚ ) (see Section 3.6). 16 W W(100) 0.09 4/0 4.04 Table 6. 54 H H(100) 0.09 3/0 4.34 site res type subst’s cvg noc/ dist 94 F F(96) 0.15 2/0 3.88 (%) bb (A˚ ) H(3) 24 D D(100) 0.09 5/1 3.72 25 P P(88) 0.21 4/1 3.02 Table 4. The top 25% of residues in 1gw9A at the interface with iodide continued in next column ion.(Field names: res: residue number in the PDB entry; type: amino acid type; substs: substitutions seen in the alignment; with the percentage of each 4 Table 6. continued Beta-l-xylopyranose binding site. Table 8 lists the top res type subst’s cvg noc/ dist 25% of residues at the interface with 1gw9ALXC1390 (beta-l- (%) bb (A˚ ) xylopyranose). The following table (Table 9) suggests possible Q(11) disruptive replacements for these residues (see Section 3.6).
Load more

Recommended publications
  • Diversity and Taxonomic Novelty of Actinobacteria Isolated from The
    Diversity and taxonomic novelty of Actinobacteria isolated from the Atacama Desert and their potential to produce antibiotics Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Christian-Albrechts-Universität zu Kiel Vorgelegt von Alvaro S. Villalobos Kiel 2018 Referent: Prof. Dr. Johannes F. Imhoff Korreferent: Prof. Dr. Ute Hentschel Humeida Tag der mündlichen Prüfung: Zum Druck genehmigt: 03.12.2018 gez. Prof. Dr. Frank Kempken, Dekan Table of contents Summary .......................................................................................................................................... 1 Zusammenfassung ............................................................................................................................ 2 Introduction ...................................................................................................................................... 3 Geological and climatic background of Atacama Desert ............................................................. 3 Microbiology of Atacama Desert ................................................................................................. 5 Natural products from Atacama Desert ........................................................................................ 9 References .................................................................................................................................. 12 Aim of the thesis ...........................................................................................................................
    [Show full text]
  • Bioactive Actinobacteria Associated with Two South African Medicinal Plants, Aloe Ferox and Sutherlandia Frutescens
    Bioactive actinobacteria associated with two South African medicinal plants, Aloe ferox and Sutherlandia frutescens Maria Catharina King A thesis submitted in partial fulfilment of the requirements for the degree of Doctor Philosophiae in the Department of Biotechnology, University of the Western Cape. Supervisor: Dr Bronwyn Kirby-McCullough August 2021 http://etd.uwc.ac.za/ Keywords Actinobacteria Antibacterial Bioactive compounds Bioactive gene clusters Fynbos Genetic potential Genome mining Medicinal plants Unique environments Whole genome sequencing ii http://etd.uwc.ac.za/ Abstract Bioactive actinobacteria associated with two South African medicinal plants, Aloe ferox and Sutherlandia frutescens MC King PhD Thesis, Department of Biotechnology, University of the Western Cape Actinobacteria, a Gram-positive phylum of bacteria found in both terrestrial and aquatic environments, are well-known producers of antibiotics and other bioactive compounds. The isolation of actinobacteria from unique environments has resulted in the discovery of new antibiotic compounds that can be used by the pharmaceutical industry. In this study, the fynbos biome was identified as one of these unique habitats due to its rich plant diversity that hosts over 8500 different plant species, including many medicinal plants. In this study two medicinal plants from the fynbos biome were identified as unique environments for the discovery of bioactive actinobacteria, Aloe ferox (Cape aloe) and Sutherlandia frutescens (cancer bush). Actinobacteria from the genera Streptomyces, Micromonaspora, Amycolatopsis and Alloactinosynnema were isolated from these two medicinal plants and tested for antibiotic activity. Actinobacterial isolates from soil (248; 188), roots (0; 7), seeds (0; 10) and leaves (0; 6), from A. ferox and S. frutescens, respectively, were tested for activity against a range of Gram-negative and Gram-positive human pathogenic bacteria.
    [Show full text]
  • Phylogenetic Study of the Species Within the Family Streptomycetaceae
    Antonie van Leeuwenhoek DOI 10.1007/s10482-011-9656-0 ORIGINAL PAPER Phylogenetic study of the species within the family Streptomycetaceae D. P. Labeda • M. Goodfellow • R. Brown • A. C. Ward • B. Lanoot • M. Vanncanneyt • J. Swings • S.-B. Kim • Z. Liu • J. Chun • T. Tamura • A. Oguchi • T. Kikuchi • H. Kikuchi • T. Nishii • K. Tsuji • Y. Yamaguchi • A. Tase • M. Takahashi • T. Sakane • K. I. Suzuki • K. Hatano Received: 7 September 2011 / Accepted: 7 October 2011 Ó Springer Science+Business Media B.V. (outside the USA) 2011 Abstract Species of the genus Streptomyces, which any other microbial genus, resulting from academic constitute the vast majority of taxa within the family and industrial activities. The methods used for char- Streptomycetaceae, are a predominant component of acterization have evolved through several phases over the microbial population in soils throughout the world the years from those based largely on morphological and have been the subject of extensive isolation and observations, to subsequent classifications based on screening efforts over the years because they are a numerical taxonomic analyses of standardized sets of major source of commercially and medically impor- phenotypic characters and, most recently, to the use of tant secondary metabolites. Taxonomic characteriza- molecular phylogenetic analyses of gene sequences. tion of Streptomyces strains has been a challenge due The present phylogenetic study examines almost all to the large number of described species, greater than described species (615 taxa) within the family Strep- tomycetaceae based on 16S rRNA gene sequences Electronic supplementary material The online version and illustrates the species diversity within this family, of this article (doi:10.1007/s10482-011-9656-0) contains which is observed to contain 130 statistically supplementary material, which is available to authorized users.
    [Show full text]
  • Database on the Taxonomical Characterisation and Potential
    EXTERNAL SCIENTIFIC REPORT APPROVED: 2 March 2017 doi:10.2903/sp.efsa.2017.EN-1274 Database on the taxonomical characterisation and potential toxigenic capacities of microorganisms used for the industrial production of food enzymes and feed additives, which do not have a recommendation for Qualified Presumption of Safety Amparo de Benito a, Clara Ibáñez a, Walter Moncho a, David Martínez a, Ariane Vettorazzi b and Adela López de Cerain b aAINIA Technology Centre, Spain bDepartment of Pharmacology and Toxicology, University of Navarra, Spain Abstract The present work constitutes the external scientific report of the EFSA open call OC/EFSA/FEED/2015/01. The aim of the call was to provide EFSA with a database from a review on the taxonomical description and potential toxigenic capacities of microorganisms used for the industrial production of feed additives and food enzymes. The review includes microorganisms used as source of feed additives and food enzymes for which EFSA has received or can potentially receive applications for safety assessment, and which have not been recommended for Qualified Presumption of Safety status. The database also comprises the molecular taxonomical identifiers and biosynthetic pathways involved in the production of toxic compounds and the responsible genes. The main result of the project is shown as a database developed according to the EFSA data structure. The methodological aspects and the queries used in the systematic search, as well as the procedure applied for the screening of scientific documents retrieved are described in this report. Details are available in supplementary appendices. In total, 22970 scientific documents were screened in the literature search, from which 411 were initially selected for providing pertinent data for the scope of the project.
    [Show full text]
  • Chapter One Introduction and Objectives
    CHAPTER ONE INTRODUCTION AND OBJECTIVES 1 CHAPTER ONE 1.1. INTRODUCTION Resistance by pathogenic bacteria has become a major health concern. Many Gram-positive bacteria and Gram-negative opportunistic pathogens were becoming resistant to virtually every clinically available drug. The emergence of multi resistant pathogenic strains has caused a therapeutic problem of enormous proportions. For instance, they cause substantial morbidity and mortality especially among the elderly and immunocompromised patients. In response, there is a renewed interest in discovering novel classes of antibiotics that have different mechanisms of action (Ogunmwonyi, 2010). Natural products have been regarded as important sources of antimicrobial compounds. There are great potential in bio-prospecting from the sea and marine natural products research has just started to bloom (Kiruthika et al., 2013). Marine microorganisms have become an important source of novel microbial products (Haggag et al., 2014). Thus, the interest of investigators was directed towards marine habitat as unusual source to be explored for the development of new drugs. Significant part of this attention has been paid to marine microorganisms, which have become important in the study of novel compounds exhibiting antibacterial, antifungal, and antitumor (Kokare et al., 2004). The dramatic increase in the prevalence of human pathogens resistant to most known antibiotics, and the emergence of new pathogens, stimulated the search for novel and potent antibiotics. Microorganisms in marine attract a great deal of attention, due to their adaptability to extreme environments. This allows the 2 organisms to produce different types of bioactive compounds including antibiotics with unique properties and applications (Mohan et al., 2013). In the last decades members of Actinomycetes became almost the most important source for antibiotics.
    [Show full text]
  • Calcium Chloride, Sodium Alginate, Or Epsilon-Polylysine Are Added (GRN 462 440)
    Microorganisms Handling/Processing 1 Identification of Petitioned Substance 2 3 Chemical Names: CAS Numbers: 4 There are many different microbial species used Bacillus subtilis 68038-70-0 5 in processing and handling. Among the most Bacillus coagulans 68038-65-3 Lactobacillus 6 common are: Aspergillus oryzae., Bacillus spp., bulgaricus 68333-15-3 7 Bifidobacteria spp., Pennicillium spp. and Rhizobus Lactococcus lactis 68814-39-1 8 spp. Leuconostoc oenos 72869-38-6 9 10 Other Name: Other Codes: 11 N/A TSCA Flag XU [Exempt from reporting under the 12 Inventory Update Rule]; TSCA UVCB 13 Trade Names: 14 15 This technical report discusses the use of microorganisms in organic processing and handling. The focus of 16 this report is the use of microorganisms in agricultural handling and processing of certified organic 17 products such as probiotics, dairy and non-dairy fermented foods and beverages, bacteriophages, and as 18 alternatives to sanitizers and cleaning agents for biological control. Yeasts are a type of microorganisms 19 used in food production, but they are outside the scope of this technical report as they are listed separately 20 on the National List. By-products and non-living components of microorganisms such as bacteriocins and 21 enzymes are also outside the scope of this report. 22 23 Summary of Petitioned Use 24 25 Microorganisms are classified as nonagricultural (nonorganic) substances that are allowed as ingredients in 26 or on processed products labeled as “organic” or “made with organic (specified ingredients or food 27 group(s)” (NOP Rule §205.605(a)). Any food grade bacteria, fungi, and other microorganisms are allowed 28 for use without restrictions in processing & handling as stated at §205.605(a).
    [Show full text]